Health Care: Drugs

Bioline Rx Ltd (BLRX: NASDAQ)

$1.33 -0.03 | -2.21%
10/22/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.36
52 Week High 3.34
52 Week Low 1.26
Avg. Daily Vol. (Mil) 0.08
Beta (3 year) 2.90
Share Related Items
Mkt Cap (Mil) 46.40
Shares Out (Mil) 34.12
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 12.20
Current Ratio 12.30
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 1.58
Price/Cash Flow -2.70
Per Share Data
Earnings -0.78
Sales 0.00
Book Value 0.86
Cash Flow -0.51
Business Summary
Bioline Rx Ltd is a clinical stage biopharmaceutical development company engaged in identifying, in-licensing & developing therapeutic compounds in areas of central nervous system, oncology, cardiovascular, & infectious diseases, among others.
General Information
19 Hartum Street
P.O.Box 45158
Jerusalem, 9777518
www.biolinerx.com
Industry : Drugs
Sector: Health Care
Employees: 43
CEO: Dr. Kinneret Savitsky, P
Short Interest
Current Month (Mil) 0.02
Previous Month (Mil) 0.05
Short Interest Ratio (Days) 0.30
Management Effectiveness
Return on Equity n.a.
Return on Assets 0.00
Return on Investments n.a.
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with BLRX

Latest BLRX Headlines from TheStreet

More Financial News for BLRX

Press Releases for BLRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter